Chemours Co (CC)
Return on equity (ROE)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 86,000 | -238,000 | 578,000 | 608,000 | 219,000 |
Total stockholders’ equity | US$ in thousands | 604,000 | 737,000 | 1,107,000 | 1,081,000 | 813,000 |
ROE | 14.24% | -32.29% | 52.21% | 56.24% | 26.94% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $86,000K ÷ $604,000K
= 14.24%
Based on the provided data, Chemours Co's return on equity (ROE) has shown significant fluctuations over the past five years.
- As of December 31, 2020, the ROE was 26.94%, indicating that for every dollar of shareholders' equity, the company generated a return of 26.94%.
- By December 31, 2021, the ROE had increased substantially to 56.24%, suggesting improved profitability and efficiency in the utilization of equity.
- The trend continued positively into December 31, 2022, with a slightly lower but still strong ROE of 52.21%.
- However, by December 31, 2023, there was a sharp decline in ROE to -32.29%, indicating that the company's net income was insufficient to cover the equity invested.
- The ROE improved again by December 31, 2024, albeit at a lower rate of 14.24%, which may suggest some challenges in sustaining high profitability levels.
Overall, the fluctuating ROE of Chemours Co indicates varying levels of profitability and efficiency in generating returns for shareholders over the past five years. It would be important to further analyze the underlying factors driving these fluctuations to assess the company's financial performance and sustainability in the long term.
Peer comparison
Dec 31, 2024